C75cad2b 7d39 4c74 85ff Bff9f1f47a60 01
Alosetron Tablet
Product Images NDC 63629-2517
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Alosetron (NDC 63629-2517). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
C75cad2b 7d39 4c74 85ff Bff9f1f47a60 02
This is a table showing the percentage of patients in different treatment groups for clinical studies 1-4. The first column indicates the percentage value, followed by the treatment groups: Placebo and Alosetron Tablets 1 mg B..D. The last two columns contain the corresponding percentage values for each group in studies 1&2 and studies 3&4.*
Label (Lbl636292517)
This text is a description of a medication called Alosetron Tablet, USP which contains Alosetron Hydrochloride, USP equivalent to 0.5 mg Alosetron. The medication comes in a film-coated tablet and should be kept out of the reach of children. It should be stored at 20° to 25°C (68° to 77°F) and dispensed in a tight, light-resistant container. The medication is supplied in a container of 30 tablets and is available only by prescription.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
